University of Florida- Jacksonville — Jacksonville, Florida

Public research footprint of University of Florida- Jacksonville, compiled from the ClinicalTrials.gov public registry.

114

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Hypertension · Carcinoma, Non-Small-Cell Lung · X-Linked Retinitis Pigmentosa (XLRP) · Proliferative Diabetic Retinopathy (PDR)

Recently updated registry entries

NCT07226791 — Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult… (Recruiting)
NCT06119581 — A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without… (Recruiting)
NCT06790784 — Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Florida- Jacksonville?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.